Bucher M, Dicent J, Hospital C, Miller G
    
    
    Neurotoxicology. 2024; 103:175-188.
  
  
    PMID: 38857676
    
          PMC: 11694735.
    
          DOI: 10.1016/j.neuro.2024.06.001.
      
 
                                  
  
    Ahuja N, Gupta S, Arora R, Bhagyaraj E, Tiwari D, Kumar S
    
    
    Life Sci Alliance. 2024; 7(7).
  
  
    PMID: 38609183
    
          PMC: 11015051.
    
          DOI: 10.26508/lsa.202302416.
      
 
                                  
  
    Xiang G, Wen X, Wang W, Peng T, Wang J, Li Q
    
    
    Parkinsons Dis. 2023; 2023:4422484.
  
  
    PMID: 37868355
    
          PMC: 10586901.
    
          DOI: 10.1155/2023/4422484.
      
 
                                  
  
    Wang Z, Chan S, Zhao H, Miu K, Chan W
    
    
    Zool Res. 2023; 44(3):559-576.
  
  
    PMID: 37161651
    
          PMC: 10236303.
    
          DOI: 10.24272/j.issn.2095-8137.2022.406.
      
 
                                  
  
    Naren P, Samim K, Tryphena K, Vora L, Srivastava S, Singh S
    
    
    Transl Neurodegener. 2023; 12(1):20.
  
  
    PMID: 37150812
    
          PMC: 10165769.
    
          DOI: 10.1186/s40035-023-00354-0.
      
 
                              
              
                              
                                      
  Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration.
  
    Mitra S, Munni Y, Dash R, Sadhu T, Barua L, Islam M
    
    
    Life (Basel). 2023; 13(4).
  
  
    PMID: 37109487
    
          PMC: 10144697.
    
          DOI: 10.3390/life13040957.
      
 
                                          
                                                          
  Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson's Disease: What We Know so Far.
  
    Sivagurunathan N, Gnanasekaran P, Calivarathan L
    
    
    Degener Neurol Neuromuscul Dis. 2023; 13:1-13.
  
  
    PMID: 36726995
    
          PMC: 9885882.
    
          DOI: 10.2147/DNND.S361526.
      
 
                                          
                                                          
  Exploring therapeutic potential of mitophagy modulators using  models of Parkinson's disease.
  
    Asthana J, Shravage B
    
    
    Front Aging Neurosci. 2022; 14:986849.
  
  
    PMID: 36337696
    
          PMC: 9632658.
    
          DOI: 10.3389/fnagi.2022.986849.
      
 
                                          
                                                          
  The selective degradation of sirtuins via macroautophagy in the MPP model of Parkinson's disease is promoted by conserved oxidation sites.
  
    Baeken M, Schwarz M, Kern A, Moosmann B, Hajieva P, Behl C
    
    
    Cell Death Discov. 2021; 7(1):286.
  
  
    PMID: 34642296
    
          PMC: 8511006.
    
          DOI: 10.1038/s41420-021-00683-x.
      
 
                                          
                                                          
  Co-editing PINK1 and DJ-1 Genes Via Adeno-Associated Virus-Delivered CRISPR/Cas9 System in Adult Monkey Brain Elicits Classical Parkinsonian Phenotype.
  
    Li H, Wu S, Ma X, Li X, Cheng T, Chen Z
    
    
    Neurosci Bull. 2021; 37(9):1271-1288.
  
  
    PMID: 34165772
    
          PMC: 8423927.
    
          DOI: 10.1007/s12264-021-00732-6.
      
 
                                          
                                                          
  Chronic-Progressive Dopaminergic Deficiency Does Not Induce Midbrain Neurogenesis.
  
    Fauser M, Pan-Montojo F, Richter C, Kahle P, Schwarz S, Schwarz J
    
    
    Cells. 2021; 10(4).
  
  
    PMID: 33807497
    
          PMC: 8066763.
    
          DOI: 10.3390/cells10040775.
      
 
                                          
                                                          
  Vulnerability of subcellular structures to pathogenesis induced by rotenone in SH-SY5Y cells.
  
    Pokusa M, Hajduchova D, Menichova V, Evinova A, Hatokova Z, Kralova-Trancikova A
    
    
    Physiol Res. 2021; 70(1):89-99.
  
  
    PMID: 33453717
    
          PMC: 8820512.
    
          DOI: 10.33549/physiolres.934477.
      
 
                                          
                                                          
  Novel Nasal Epithelial Cell Markers of Parkinson's Disease Identified Using Cells Treated with α-Synuclein Preformed Fibrils.
  
    Kim H, Kang S, Jo Y, Park S, Yun S, Lee Y
    
    
    J Clin Med. 2020; 9(7).
  
  
    PMID: 32640699
    
          PMC: 7408990.
    
          DOI: 10.3390/jcm9072128.
      
 
                                          
                                                          
  Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis.
  
    Harsanyiova J, Buday T, Kralova Trancikova A
    
    
    Front Neurosci. 2020; 14:626.
  
  
    PMID: 32625058
    
          PMC: 7313629.
    
          DOI: 10.3389/fnins.2020.00626.
      
 
                                          
                                                          
  Toward the Optimization of (+)-[C]PHNO Synthesis: Time Reduction and Process Validation.
  
    Pfaff S, Philippe C, Nics L, Berroteran-Infante N, Pallitsch K, Rami-Mark C
    
    
    Contrast Media Mol Imaging. 2019; 2019:4292596.
  
  
    PMID: 31656452
    
          PMC: 6791232.
    
          DOI: 10.1155/2019/4292596.
      
 
                                          
                                                          
  Versatile cell ablation tools and their applications to study loss of cell functions.
  
    Liu F, Dai S, Feng D, Peng X, Qin Z, Kearns A
    
    
    Cell Mol Life Sci. 2019; 76(23):4725-4743.
  
  
    PMID: 31359086
    
          PMC: 6858955.
    
          DOI: 10.1007/s00018-019-03243-w.
      
 
                                          
                                                          
  Dopamine Cytotoxicity on SH-SY5Y Cells: Involvement of α-Synuclein and Relevance in the Neurodegeneration of Sporadic Parkinson's Disease.
  
    Ganguly U, Ganguly A, Sen O, Ganguly G, Cappai R, Sahoo A
    
    
    Neurotox Res. 2019; 35(4):898-907.
  
  
    PMID: 30806984
    
    
          DOI: 10.1007/s12640-019-0001-0.
      
 
                                          
                                                          
  Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors.
  
    Jakaria M, Park S, Haque M, Karthivashan G, Kim I, Ganesan P
    
    
    Front Mol Neurosci. 2018; 11:307.
  
  
    PMID: 30210294
    
          PMC: 6123546.
    
          DOI: 10.3389/fnmol.2018.00307.
      
 
                                          
                                                          
  Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
  
    Lai F, Jiang R, Xie W, Liu X, Tang Y, Xiao H
    
    
    Neurochem Res. 2018; 43(10):1986-1999.
  
  
    PMID: 30171422
    
    
          DOI: 10.1007/s11064-018-2620-x.
      
 
                                          
                                                          
  Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases.
  
    Joshi A, Mochly-Rosen D
    
    
    Pharmacol Res. 2018; 138:2-15.
  
  
    PMID: 30144530
    
          PMC: 6263811.
    
          DOI: 10.1016/j.phrs.2018.08.010.